Page last updated: 2024-10-25

cimetidine and Sarcoma 180

cimetidine has been researched along with Sarcoma 180 in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Sarcoma 180: An experimental sarcoma of mice.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerutti, I1
Chany, C1
Kabuta, H1
Tanaka, M1
Noda, Y1
Yamamoto, S1
Shingu, M1

Other Studies

2 other studies available for cimetidine and Sarcoma 180

ArticleYear
Coordinated therapeutic effects of immune modulators and interferon.
    Infection and immunity, 1983, Volume: 42, Issue:2

    Topics: Adjuvants, Immunologic; Animals; Carcinoma, Ehrlich Tumor; Cimetidine; Ditiocarb; Encephalomyocardit

1983
Natural killer (NK) cell activity of mice treated with herpes simplex virus type-2, sarcoma-180 cells, cyclosporine and cimetidine.
    The Kurume medical journal, 1990, Volume: 37, Issue:4

    Topics: Animals; Cimetidine; Cyclosporins; Killer Cells, Natural; Mice; Mice, Inbred BALB C; Sarcoma 180; Si

1990